GPRC5D-Targeted Therapies in Relapsed Multiple Myeloma

Opinion
Video

Panelists discuss how their clinical experience with GPRC5D bispecific therapies has been limited or nonexistent due to the novelty of these treatments in multiple myeloma.

Recent Videos
3 experts in this video
Related Content